Molecular Diagnostics Market 2023 Future Insight - All Set to Reach Strong CAGR with Top Merchants | Industry is booming by PCR Technology ; Finds MRFR
Molecular Diagnostics Market Research Report – Forecast to 2023 exclusively available at MarketResearchFuture.com with unique information collected by industry experts through interview. Report include market recent trends, market demand, size, shares and growth analysis by 2023. Global Molecular Diagnostics Market is expected to grow at a CAGR of 9.6% during forecasted period 2018-2023. Molecular diagnostics is a branch of diagnostics which utilizes molecular biology to detect and measure the presence of genetic material or proteins related to a specific health condition. Molecular diagnostics is an integral part of in-vitro diagnostics, used to detect definite sequences in DNA/RNA, or in single nucleotide polymorphism (SNP), rearrangements, insertions and deletions. It is a collection of techniques used to analyse biomarkers in genomics and proteomics. Molecular diagnostics plays a vital role in infectious disease testing as they provide fast and effective results. Molecular diagnostics is a significant tool when it is essential to diagnose and treat at molecular level. Molecular diagnostics market is driven by advancements in technology as they provide higher accuracy and cost-effectiveness. The growing incidence of infectious diseases and various types of cancers rise in awareness programs, progress in biomarker identification, acceptance of personalized medicines are the factors expected to drive the market growth over the forecast period. Additionally, rise in occurrence rates of cardiovascular disorders, genetic disorders, neurological disorders are also expected to fuel the market growth. Get Sample Copy of Report https://www.marketresearchfuture.com/sample_request/1171
@
Key players for Global Molecular Diagnostics Market Hoffmann-La Roche Ltd. (U.S.), QIAGEN N.V. (the Netherlands), Hologic, Inc. (U.S.), Grifols (Spain), Abbott (U.S.), Siemens Healthcare GmbH (Germany), Bio-Rad Laboratories, Inc. (US), BD (U.S.), Beckman Coulter Inc. (U.S.), bioMĂŠrieux SA (France), and Cepheid (U.S.), Danaher (U.S.). The North America dominates the global market for molecular diagnostics as it holds the highest market share due to increasing demand for the advanced techniques in molecular diagnostics, large elderly population, increase in the number of cases of infectious and chronic diseases, and acceptance of personalized medicines are the major factors for the growth of American market.